BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22296276)

  • 21. Clear cell chondrosarcoma in Von Hippel-Lindau disease.
    Dreijerink KMA; van Leeuwaarde RS; Hackeng WM; Giles RH; de Leng WWJ; Jutte PC; Suurmeijer AJH; van Nesselrooij BPM; Brosens LAA
    Fam Cancer; 2020 Jan; 19(1):41-45. PubMed ID: 31673890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary cystadenoma of the broad ligament in von Hippel-Lindau disease.
    Korn WT; Schatzki SC; DiSciullo AJ; Scully RE
    Am J Obstet Gynecol; 1990 Aug; 163(2):596-8. PubMed ID: 2386149
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
    Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.
    Skalova A; Síma R; Bohus P; Curík R; Lukás J; Michal M
    Pathol Res Pract; 2008; 204(8):599-606. PubMed ID: 18423895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.
    Petersson F; Grossmann P; Hora M; Sperga M; Montiel DP; Martinek P; Gutierrez ME; Bulimbasic S; Michal M; Branzovsky J; Hes O
    Hum Pathol; 2013 Jul; 44(7):1412-20. PubMed ID: 23434146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Papillary cystadenoma of the epididymis: a case report.
    Lissens P; Michiels H; Geysens P; Van de Voorde W; Lauweryns J
    Acta Urol Belg; 1995 Mar; 63(1):109-12. PubMed ID: 7725985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clear cell papillary renal cell carcinoma-like tumors in patients with von Hippel-Lindau disease are unrelated to sporadic clear cell papillary renal cell carcinoma.
    Williamson SR; Zhang S; Eble JN; Grignon DJ; Martignoni G; Brunelli M; Wang M; Gobbo S; Baldridge LA; Cheng L
    Am J Surg Pathol; 2013 Aug; 37(8):1131-9. PubMed ID: 23648463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.
    Rao P; Monzon F; Jonasch E; Matin SF; Tamboli P
    Hum Pathol; 2014 Sep; 45(9):1966-72. PubMed ID: 25081542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
    Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
    Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline mutation of von Hippel-Lindau (VHL) gene 695 G>A (R161Q) in a patient with a peculiar phenotype with type 2C VHL syndrome.
    Santarpia L; Lapa D; Benvenga S
    Ann N Y Acad Sci; 2006 Aug; 1073():198-202. PubMed ID: 17102087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
    Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
    Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clear Cell Papillary Cystadenoma of the Ovary Masquerading as Metastatic Clear Cell Renal Cell Carcinoma: A Case Report and Review of the Literature.
    Sharma AE; Hamedani FS; Barroeta JE; Pytel P; Bennett JA; Lastra RR
    Int J Gynecol Pathol; 2021 May; 40(3):290-295. PubMed ID: 31985579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
    Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
    Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Papillary cystadenoma of the epididymis revealing von Hippel-Lindau disease].
    Handra-Luca A; Toublanc M; Richard S; Polivka M; Boccon-Gibod L; Hénin D
    Ann Pathol; 2001 Feb; 21(1):102-3. PubMed ID: 11223573
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications.
    Walther MM; Lubensky IA; Venzon D; Zbar B; Linehan WM
    J Urol; 1995 Dec; 154(6):2010-4; discussion 2014-5. PubMed ID: 7500446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.